NCT06726811 Droperidol and QTc Interval Changes in ED Patients
| NCT ID | NCT06726811 |
| Status | Recruiting |
| Phase | — |
| Sponsor | CHRISTUS Health |
| Condition | Emergency Department Patient |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-10-17 |
| Primary Completion | 2025-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2024-10-17 with a primary completion date of 2025-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Objectives To assess the association of low-dose Droperidol administration in the emergency department with changes in the QTc interval. Hypothesis Our study is designed to test the null hypothesis that there will be no clinically significant change in QTc interval after administration of 2.5mg of IV Droperidol during an emergency department visit.
Eligibility Criteria
Inclusion Criteria: * ED patients ages 18 years or older in a cardiovascular-monitored bed who have both an ECG and a 2.5 mg dose of IV droperidol ordered by their treating physician will be eligible for inclusion. Exclusion Criteria: * Refusal to provide consent. * Administration of droperidol before the first ECG is performed. * Inability to complete the consent form and questionnaire due to clinical instability, severe pain, or disorientation as determined by a study physician.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06726811 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Emergency Department Patient. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06726811 currently recruiting?
Yes, NCT06726811 is actively recruiting participants. Contact the research team at aaronkbartoe@gmail.com for enrollment information.
Where is the NCT06726811 trial being conducted?
This trial is being conducted at Corpus Christi, United States.
Who is sponsoring the NCT06726811 clinical trial?
NCT06726811 is sponsored by CHRISTUS Health. The trial plans to enroll 500 participants.